These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25848521)

  • 1. Immunogenicity comparison of conjugate vaccines composed of alginate and lipopolysaccharide of Pseudomonas aeruginosa bound to diphtheria toxoid.
    Najafzadeh F; Jaberi G; Shapouri R; Rahnema M; Karimi-Nik A; Kianmehr A
    Iran J Microbiol; 2014 Oct; 6(5):317-23. PubMed ID: 25848521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity.
    Najafzadeh F; Shapouri R; Rahnema M; Rokhsartalab Azar S; Kianmehr A
    Jundishapur J Microbiol; 2015 Jun; 8(6):e17712. PubMed ID: 26301059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and immunological properties of Escherichia coli 0157:H7 lipopolysaccharide- diphtheria toxoid conjugate vaccine.
    Rokhsartalab-Azar S; Shapouri R; Rahnema M; Najafzadeh F; Kianmehr A
    Iran J Microbiol; 2015 Jun; 7(3):150-5. PubMed ID: 26668702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate.
    Kashef N; Behzadian-Nejad Q; Najar-Peerayeh S; Mousavi-Hosseini K; Moazzeni M; Djavid GE
    J Med Microbiol; 2006 Oct; 55(Pt 10):1441-1446. PubMed ID: 17005795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological Properties of Exotoxin A Toxoid - Detoxified Lipopolysaccharide - Gold Nanoparticles Conjugate Against Pseudomonas aeruginosa Infection.
    Najafzadeh F; Tanomand A; Haddadi A; Majidi J
    Iran J Immunol; 2021 Dec; 18(4):292-303. PubMed ID: 34931615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans.
    Cryz SJ; Sadoff JC; Fürer E; Germanier R
    J Infect Dis; 1986 Oct; 154(4):682-8. PubMed ID: 3091708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.
    Cryz SJ; Fürer E; Que JU
    Infect Immun; 1991 Jan; 59(1):45-50. PubMed ID: 1898901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physico-chemical properties of Salmonella typhi Vi polysaccharide-diphtheria toxoid conjugate vaccines affect immunogenicity.
    An SJ; Yoon YK; Kothari S; Kothari N; Kim JA; Lee E; Kim DR; Park TH; Smith GW; Carbis R
    Vaccine; 2011 Oct; 29(44):7618-23. PubMed ID: 21843575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK
    APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Immunogenicity of Diphtheria Toxoid Conjugated to Salmonella Typhimurium-Derived OPS in a Mouse Model: A Potential Vaccine Candidate Against Salmonellosis.
    Amini V; Kazemian H; Yamchi JK; Feyisa SG; Aslani S; Shavalipour A; Houri H; Hoorijani M; Halaji M; Heidari H
    Iran Red Crescent Med J; 2016 Jul; 18(7):e34135. PubMed ID: 27660722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate.
    Fattom A; Shiloach J; Bryla D; Fitzgerald D; Pastan I; Karakawa WW; Robbins JB; Schneerson R
    Infect Immun; 1992 Feb; 60(2):584-9. PubMed ID: 1730492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of Pseudomonas aeruginosa alginate-flagellin immunoconjugate.
    Faezi S; Bahrmand AR; Mahdavi M; Siadat SD; Sardari S; Nikokar I; Khanaki K; Mirzajani E; Goudarzi G
    Biologicals; 2017 May; 47():11-17. PubMed ID: 28404459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity evaluating of the SLNs-alginate conjugate against Pseudomonas aeruginosa.
    Afshari H; Maleki M; Hakimian M; Tanha RA; Salouti M
    J Immunol Methods; 2021 Jan; 488():112938. PubMed ID: 33259781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from Pseudomonas aeruginosa in mice.
    Gholami M; Chirani AS; Razavi S; Falak R; Irajian G
    Lett Appl Microbiol; 2017 Nov; 65(5):439-445. PubMed ID: 28857243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
    Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
    Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa PAO1 outer membrane vesicles-diphtheria toxoid conjugate as a vaccine candidate in a murine burn model.
    Zare Banadkoki E; Rasooli I; Ghazanfari T; Siadat SD; Shafiee Ardestani M; Owlia P
    Sci Rep; 2022 Dec; 12(1):22324. PubMed ID: 36566282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization against
    Azimi S; Safari Zanjani L
    Iran J Basic Med Sci; 2021 Apr; 24(4):476-482. PubMed ID: 34094029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.
    Boutonnier A; Villeneuve S; Nato F; Dassy B; Fournier JM
    Infect Immun; 2001 May; 69(5):3488-93. PubMed ID: 11292781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of immunogenic conjugates of Salmonella enterica serovar Typhi O-specific polysaccharides with diphtheria toxoid.
    Ali A; An SJ; Cui C; Haque A; Carbis R
    Hum Vaccin Immunother; 2012 Feb; 8(2):189-93. PubMed ID: 22426380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of two new nanovaccines against Pseudomonas aeruginosa based on LPS and OPS: A comparison study.
    Maleki M; Azimi S; Salouti M
    Immunobiology; 2022 Nov; 227(6):152278. PubMed ID: 36115097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.